Photodynamic Therapy for Oral Leukoplakia and Erythroleukoplakia

This study has been completed.
Sponsor:
Information provided by:
National Taiwan University Hospital
ClinicalTrials.gov Identifier:
NCT00155337
First received: September 8, 2005
Last updated: December 20, 2012
Last verified: December 2012

September 8, 2005
December 20, 2012
August 2004
December 2007   (final data collection date for primary outcome measure)
End of 8 treatments
Same as current
Complete list of historical versions of study NCT00155337 on ClinicalTrials.gov Archive Site
Regression of lesions
Same as current
Not Provided
Not Provided
 
Photodynamic Therapy for Oral Leukoplakia and Erythroleukoplakia
Photodynamic Therapy for Oral Leukoplakia and Erythroleukoplakia

Photodynamic therapy for oral leukoplakia and erythroleukoplakia

Photodynamic therapy for oral leukoplakia and erythroleukoplakia

Interventional
Phase 4
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Oral Leukoplakia
Procedure: photodynamic therapy
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
40
December 2007
December 2007   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • patients with leukoplakia or erythroleukoplakia

Exclusion Criteria:

  • oral cancers
Both
20 Years to 80 Years
No
Contact information is only displayed when the study is recruiting subjects
Taiwan
 
NCT00155337
9361700753
Not Provided
Not Provided
National Taiwan University Hospital
Not Provided
Principal Investigator: Chun-Pin Chiang, DMSc National Taiwan University Hospital
National Taiwan University Hospital
December 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP